[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100606945":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":30,"responsibleParty":188,"collaborators":19,"id":190,"slug":191,"hasResults":192,"nctId":193,"briefTitle":194,"officialTitle":195,"acronym":19,"eligibilityCriteria":196,"healthyVolunteers":192,"sex":197,"minAge":198,"maxAge":19,"enrollmentInfo":199,"targetDuration":19,"studyType":202,"phases":203,"briefSummary":205,"conditions":206,"keywords":217,"overallStatus":33,"whyStopped":19,"lastUpdateSubmitDate":218,"lastUpdatePostDateStruct":219,"startDateStruct":222,"completionDateStruct":224,"leadSponsor":226,"locationsCount":227},{"fullName":5,"class":6},"Normunity AccelCo, Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"NRM-823","EXPERIMENTAL","Administered per protocol requirements",[13],"Drug: NRM-823",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DRUG","NRM-823 is a bispecific T-Cell Engager",[9],null,[21],{"name":22,"affiliation":5,"role":23},"Viviana Bozon, MD","STUDY_DIRECTOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":19,"email":29},"Judy Schnyder, MBA","CONTACT","215-593-7119","judy.schnyder@normunity.com",[31,45,54,63,72,77,86,95,104,113,122,131,136,145,154,163,171,179],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":19},"Normunity Investigational Site","RECRUITING","Denver","Colorado","80220","United States","US",{"type":40,"coordinates":41},"Point",[42,43],-104.9847,39.73915,{"lat":43,"lon":42},{"facility":32,"status":33,"city":46,"state":47,"zip":48,"country":37,"countryCode":38,"cosmosGeoPoint":49,"geoPoint":53,"contacts":19},"New Haven","Connecticut","06519",{"type":40,"coordinates":50},[51,52],-72.92816,41.30815,{"lat":52,"lon":51},{"facility":32,"status":33,"city":55,"state":56,"zip":57,"country":37,"countryCode":38,"cosmosGeoPoint":58,"geoPoint":62,"contacts":19},"Washington D.C.","District of Columbia","20007",{"type":40,"coordinates":59},[60,61],-77.03637,38.89511,{"lat":61,"lon":60},{"facility":32,"status":33,"city":64,"state":65,"zip":66,"country":37,"countryCode":38,"cosmosGeoPoint":67,"geoPoint":71,"contacts":19},"Boston","Massachusetts","02114",{"type":40,"coordinates":68},[69,70],-71.05977,42.35843,{"lat":70,"lon":69},{"facility":32,"status":33,"city":64,"state":65,"zip":73,"country":37,"countryCode":38,"cosmosGeoPoint":74,"geoPoint":76,"contacts":19},"02215",{"type":40,"coordinates":75},[69,70],{"lat":70,"lon":69},{"facility":32,"status":33,"city":78,"state":79,"zip":80,"country":37,"countryCode":38,"cosmosGeoPoint":81,"geoPoint":85,"contacts":19},"Minneapolis","Minnesota","55425",{"type":40,"coordinates":82},[83,84],-93.26384,44.97997,{"lat":84,"lon":83},{"facility":32,"status":33,"city":87,"state":88,"zip":89,"country":37,"countryCode":38,"cosmosGeoPoint":90,"geoPoint":94,"contacts":19},"St Louis","Missouri","63108",{"type":40,"coordinates":91},[92,93],-90.19789,38.62727,{"lat":93,"lon":92},{"facility":32,"status":33,"city":96,"state":97,"zip":98,"country":37,"countryCode":38,"cosmosGeoPoint":99,"geoPoint":103,"contacts":19},"Hackensack","New Jersey","07601",{"type":40,"coordinates":100},[101,102],-74.04347,40.88593,{"lat":102,"lon":101},{"facility":32,"status":33,"city":105,"state":106,"zip":107,"country":37,"countryCode":38,"cosmosGeoPoint":108,"geoPoint":112,"contacts":19},"Maumee","Ohio","43537",{"type":40,"coordinates":109},[110,111],-83.65382,41.56283,{"lat":111,"lon":110},{"facility":32,"status":33,"city":114,"state":115,"zip":116,"country":37,"countryCode":38,"cosmosGeoPoint":117,"geoPoint":121,"contacts":19},"Oklahoma City","Oklahoma","73104",{"type":40,"coordinates":118},[119,120],-97.51643,35.46756,{"lat":120,"lon":119},{"facility":32,"status":33,"city":123,"state":124,"zip":125,"country":37,"countryCode":38,"cosmosGeoPoint":126,"geoPoint":130,"contacts":19},"Philadelphia","Pennsylvania","19107",{"type":40,"coordinates":127},[128,129],-75.16362,39.95238,{"lat":129,"lon":128},{"facility":32,"status":33,"city":123,"state":124,"zip":132,"country":37,"countryCode":38,"cosmosGeoPoint":133,"geoPoint":135,"contacts":19},"19111",{"type":40,"coordinates":134},[128,129],{"lat":129,"lon":128},{"facility":32,"status":33,"city":137,"state":138,"zip":139,"country":37,"countryCode":38,"cosmosGeoPoint":140,"geoPoint":144,"contacts":19},"Charleston","South Carolina","29425",{"type":40,"coordinates":141},[142,143],-79.93275,32.77632,{"lat":143,"lon":142},{"facility":32,"status":33,"city":146,"state":147,"zip":148,"country":37,"countryCode":38,"cosmosGeoPoint":149,"geoPoint":153,"contacts":19},"Nashville","Tennessee","37203",{"type":40,"coordinates":150},[151,152],-86.78444,36.16589,{"lat":152,"lon":151},{"facility":32,"status":33,"city":155,"state":156,"zip":157,"country":37,"countryCode":38,"cosmosGeoPoint":158,"geoPoint":162,"contacts":19},"Dallas","Texas","75230",{"type":40,"coordinates":159},[160,161],-96.80667,32.78306,{"lat":161,"lon":160},{"facility":32,"status":33,"city":164,"state":156,"zip":165,"country":37,"countryCode":38,"cosmosGeoPoint":166,"geoPoint":170,"contacts":19},"Houston","77030",{"type":40,"coordinates":167},[168,169],-95.36327,29.76328,{"lat":169,"lon":168},{"facility":32,"status":33,"city":172,"state":156,"zip":173,"country":37,"countryCode":38,"cosmosGeoPoint":174,"geoPoint":178,"contacts":19},"San Antonio","78229",{"type":40,"coordinates":175},[176,177],-98.49363,29.42412,{"lat":177,"lon":176},{"facility":32,"status":33,"city":180,"state":181,"zip":182,"country":37,"countryCode":38,"cosmosGeoPoint":183,"geoPoint":187,"contacts":19},"Fairfax","Virginia","22031",{"type":40,"coordinates":184},[185,186],-77.30637,38.84622,{"lat":186,"lon":185},{"type":189,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100606945","phase-1-a-phase-1-study-of-nrm-823-in-participants-with-locally-advanced-or-metastatic-refractory-solid-tumors-100606945",false,"NCT07182149","A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors","A Phase 1a\u002F1b Study of NRM-823 as Monotherapy and in Combination With Immune Checkpoint Inhibition in Participants With Locally Advanced or Metastatic Refractory Solid Tumors","Inclusion Criteria:\n\n* Have histologically- or cytologically-diagnosed NSCLC (squamous or adenocarcinoma), TNBC, HNSCC, ESCC, esophageal adenocarcinoma, gastric\u002FGEJ adenocarcinoma, cervical, endometrial, or ovarian cancer which is advanced or metastatic.\n* Have an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1.\n* Adequate liver, renal, pulmonary, and cardiac function.\n* Adequate hematologic function.\n\nExclusion Criteria:\n\n* Has received cytotoxic chemotherapy, biologic anticancer agents, checkpoint inhibitors, or radiation therapy (excluding bone-only radiation therapy) ≤3 weeks or 5 half-lives (whichever is shorter) prior to the first dose of NRM-823\n* History of Grade 2 pneumonitis requiring steroids or any Grade 3 or 4 pneumonitis from any prior therapy.\n* Has received an investigational therapy \\\u003C4 weeks or 5 half-lives prior to the first dose of NRM823, whichever is shorter prior to the first dose of NRM-823.\n* With the exception of alopecia and Grade ≤2 neuropathy, any unresolved toxicities from prior therapy greater than CTCAE Grade 1 at the time of starting study drug.","ALL","18 Years",{"count":200,"type":201},150,"ESTIMATED","INTERVENTIONAL",[204],"PHASE1","This study is being done to find out of NRM-823 is safe and can treat participants with locally advanced or metastatic solid tumors.",[207,208,209,210,211,212,213,214,215,216],"HNSCC","ESCC","Esophageal Adenocarcinoma","Gastric Adenocarcinoma","GEJ Adenocarcinoma","Ovarian Cancer","NSCLC","Cervical Cancer","Endometrial Cancer","Triple Negative Breast Cancer (TNBC)",[9],"2026-08-17",{"date":220,"type":221},"2026-08-18","ACTUAL",{"date":223,"type":221},"2025-10-30",{"date":225,"type":201},"2028-10-31",{"name":5,"class":6},18]